Kathleen Rickard

2022

In 2022, Kathleen Rickard earned a total compensation of $1.5M as Chief Medical Officer at Verona Pharma plc, a 170% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$217,220
Salary$434,439
Stock Awards$863,000
Other$3,342
Total$1,518,001

Rickard received $863K in stock awards, accounting for 57% of the total pay in 2022.

Rickard also received $217.2K in non-equity incentive plan, $434.4K in salary and $3.3K in other compensation.

Rankings

In 2022, Kathleen Rickard's compensation ranked 2,202nd out of 5,736 executives tracked by ExecPay. In other words, Rickard earned more than 61.6% of executives.

ClassificationRankingPercentile
All
2,202
out of 5,736
62nd
Division
Manufacturing
1,191
out of 3,125
62nd
Major group
Chemicals And Allied Products
514
out of 1,416
64th
Industry group
Drugs
474
out of 1,317
64th
Industry
Pharmaceutical Preparations
346
out of 963
64th
Source: SEC filing on March 21, 2023.

Rickard's colleagues

We found two more compensation records of executives who worked with Kathleen Rickard at Verona Pharma plc in 2022.

2022

David Zaccardelli

Verona Pharma plc

Chief Executive Officer

2022

Mark Hahn

Verona Pharma plc

Chief Financial Officer

News

You may also like